Product Description Take control of your type 2 diabetes with Bexagliflozin (Bexacat™), a once-daily oral tablet that belongs to the innovative SGLT2 inhibitor class. By blocking glucose reabsorption in the kidneys and promoting its excretion in urine, bexagliflozin effectively lowers blood sugar levels, supports weight loss, and reduces cardiovascular risks - all with a convenient single pill.
Key Benefits & Functionalities
- Significantly lowers A1C (proven reduction of up to ~0.9-1.1% in clinical studies)
- Promotes modest weight loss (average 3-6 lbs)
- Lowers risk of heart failure hospitalization in patients with type 2 diabetes
- Improves glycemic control as monotherapy or in combination with metformin, sulfonylureas, insulin, etc.
- Once-daily dosing with no need for titration
Recommended Dosage & Usage
- Standard dose: 20 mg once daily
- Take in the morning, with or without food
- Swallow whole - do not crush or chew
- Suitable for adults with type 2 diabetes; not for type 1 diabetes or diabetic ketoacidosis
Common Side Effects
- Urinary tract infections (UTIs)
- Female genital mycotic (yeast) infections
- Increased urination
- Thirst or dehydration
- Rare but serious: ketoacidosis, severe urinary tract infections, necrotizing fasciitis of the perineum (Fournier’s gangrene), lower limb amputations (risk factor-based)
Important Safety Information Stay well-hydrated and maintain good genital hygiene to reduce infection risk. Monitor for signs of dehydration, especially if you have kidney issues or are on diuretics. Not recommended during the second and third trimesters of pregnancy. Consult your doctor before starting if you have kidney problems, are on a low-sodium diet, or have a history of amputation.
Empower your diabetes management with proven, modern therapy - add Bexagliflozin 20 mg to your daily routine today!